C
60.08
0.63 (1.05%)
| Previous Close | 59.45 |
| Open | 59.16 |
| Volume | 459,984 |
| Avg. Volume (3M) | 5,243,779 |
| Market Cap | 29,799,843,840 |
| Price / Earnings (TTM) | 9.52 |
| Price / Earnings (Forward) | 7.92 |
| Price / Sales | 0.190 |
| Price / Book | 1.09 |
| 52 Weeks Range | |
| Earnings Date | 25 Apr 2025 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 1.48% |
| Diluted EPS (TTM) | 6.31 |
| Quarterly Revenue Growth (YOY) | 2.30% |
| Quarterly Earnings Growth (YOY) | 528.90% |
| Total Debt/Equity (MRQ) | 73.29% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 154.00 M |
| Levered Free Cash Flow (TTM) | 653.12 M |
| Return on Assets (TTM) | 3.70% |
| Return on Equity (TTM) | 12.56% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bearish |
| Healthcare Plans (Global) | Bullish | Bearish | |
| Stock | Centene Corporation | Bearish | Bearish |
AIStockmoo Score
-0.7
| Analyst Consensus | 1.0 |
| Insider Activity | -3.0 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.70 |
|
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.44% |
| % Held by Institutions | 100.43% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 31 Dec 2024 | 8,772,434 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 84.00 (Barclays, 39.83%) | Buy |
| Median | 70.50 (17.35%) | |
| Low | 61.00 (Jefferies, 1.54%) | Hold |
| Average | 71.50 (19.02%) | |
| Total | 2 Buy, 2 Hold | |
| Avg. Price @ Call | 59.47 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 29 Apr 2025 | 61.00 (1.54%) | Hold | 59.26 |
| 08 Apr 2025 | 64.00 (6.53%) | Hold | 62.40 | |
| Barclays | 28 Apr 2025 | 84.00 (39.83%) | Buy | 59.47 |
| Baird | 15 Apr 2025 | 69.00 (14.86%) | Hold | 62.28 |
| Wells Fargo | 14 Feb 2025 | 72.00 (19.85%) | Buy | 56.86 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ASHER ANDREW LYNN | - | 57.69 | -10,566 | -609,553 |
| Aggregate Net Quantity | -10,566 | |||
| Aggregate Net Value ($) | -609,553 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 57.69 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ASHER ANDREW LYNN | Officer | 26 Apr 2025 | Disposed (-) | 10,566 | 57.69 | 609,553 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |